BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11584134)

  • 1. Natures antibiotics: the potential of antimicrobial peptides as new drugs.
    Diamond G
    Biologist (London); 2001 Oct; 48(5):209-12. PubMed ID: 11584134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antimicrobial peptides: a new way to treat bacterial infections].
    Igaz P
    Orv Hetil; 2001 Jan; 142(4):169-71. PubMed ID: 11232153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial peptides: new candidates in the fight against bacterial infections.
    Toke O
    Biopolymers; 2005; 80(6):717-35. PubMed ID: 15880793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old and new targets of antibacterial therapy.
    Dbaibo GS
    J Med Liban; 2000; 48(4):177-81. PubMed ID: 11214186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of novel hybrid peptides from LFB15(W4,10), HP(2-20), and cecropin A based on structure parameters by computer-aided method.
    Tian ZG; Dong TT; Teng D; Yang YL; Wang JH
    Appl Microbiol Biotechnol; 2009 Apr; 82(6):1097-103. PubMed ID: 19148638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic use: present and future.
    Zinner SH
    New Microbiol; 2007 Jul; 30(3):321-5. PubMed ID: 17802919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy among antibacterial peptides and between peptides and small-molecule antibiotics.
    Cassone M; Otvos L
    Expert Rev Anti Infect Ther; 2010 Jun; 8(6):703-16. PubMed ID: 20521897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plectasin - a new peptide antibiotic with high therapeutic potential].
    Schmitz J; Holzgrabe U
    Pharm Unserer Zeit; 2010 Sep; 39(5):336-8. PubMed ID: 20818681
    [No Abstract]   [Full Text] [Related]  

  • 9. [Natural antimicrobial peptides--promising new antibiotics or a problem later on?].
    Vorland LH
    Tidsskr Nor Laegeforen; 2001 Nov; 121(27):3191-6. PubMed ID: 11876145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial targets to antimicrobial leads and development candidates.
    Rogers BL
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):211-22. PubMed ID: 15603255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibacterial chemotherapy--are we really at the end of the antibiotic era?].
    Vacek V
    Cas Lek Cesk; 2001 Sep; 140(19):592-5. PubMed ID: 11715728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates.
    Pag U; Oedenkoven M; Papo N; Oren Z; Shai Y; Sahl HG
    J Antimicrob Chemother; 2004 Feb; 53(2):230-9. PubMed ID: 14729742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria.
    Hale JD; Hancock RE
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):951-9. PubMed ID: 18039080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance.
    Lieberman JM
    Pediatr Infect Dis J; 2003 Dec; 22(12):1143-51. PubMed ID: 14688589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence requirements and an optimization strategy for short antimicrobial peptides.
    Hilpert K; Elliott MR; Volkmer-Engert R; Henklein P; Donini O; Zhou Q; Winkler DF; Hancock RE
    Chem Biol; 2006 Oct; 13(10):1101-7. PubMed ID: 17052614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial drug discovery and development--SRI's 11th Annual Summit. Antibacterial trends and current research.
    Silver LL
    IDrugs; 2006 Jun; 9(6):394-7. PubMed ID: 16752305
    [No Abstract]   [Full Text] [Related]  

  • 17. A guide to antibiotic resistance in bacterial skin infections.
    Perera G; Hay R
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):531-45. PubMed ID: 16164705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs.
    Cherkasov A; Hilpert K; Jenssen H; Fjell CD; Waldbrook M; Mullaly SC; Volkmer R; Hancock RE
    ACS Chem Biol; 2009 Jan; 4(1):65-74. PubMed ID: 19055425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo design of selective antibiotic peptides by incorporation of unnatural amino acids.
    Hicks RP; Bhonsle JB; Venugopal D; Koser BW; Magill AJ
    J Med Chem; 2007 Jun; 50(13):3026-36. PubMed ID: 17547385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceragenins: cholic acid-based mimics of antimicrobial peptides.
    Lai XZ; Feng Y; Pollard J; Chin JN; Rybak MJ; Bucki R; Epand RF; Epand RM; Savage PB
    Acc Chem Res; 2008 Oct; 41(10):1233-40. PubMed ID: 18616297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.